Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Evaluation of photobiomodulation in salivary production of patients with xerostomy induced by anti-hypertensive drugs

2020; Wolters Kluwer; Volume: 99; Issue: 16 Linguagem: Inglês

10.1097/md.0000000000019583

ISSN

1536-5964

Autores

Maria Lúcia Zarvos Varellis, Marcela Letícia Leal Gonçalves, Vanessa Christina Santos Pavesi, Anna Carolina Ratto Tempestini Horliana, Daniela de Fátima Teixeira da Silva, Lara Jansiski Motta, Valdomiro Francisco Barbosa-Filho, Cícero Dayves Silva Bezerra, Felipe Gonçalves da Silva, Sandra Kalil Bussadori, Alessandro Melo Deana,

Tópico(s)

Oral microbiology and periodontitis research

Resumo

Abstract Introduction: Hypertension (systemic arterial hypertension [SAH]) is a systemic condition that affects about 30% of the world population, according to data from the World Health Organization (WHO). Drugs used to control this disease have the potential to induce xerostomia, an oral condition in which the decrease of the salivary flow is observed and whose presence leads to the increase of the index of caries, periodontal disease, loss of the teeth, dysgeusia, difficulty of mastication, dysphagia, bad breath and oral burning and impairment of prothesis installed in the buccal cavity, including retention of removable and total dentures. Methods: This is a randomized, placebo-controlled, blind clinical protocol that aims to analyze the impact of phobiomodulation (PBM) on salivary glands of patients with antihypertensive drug induced xerostomia. Patients will be divided into 2 groups: G1: older adults with xerostomia induced by antihypertensive drugs and treatment with PBM (n = 30); G2: placebo PBM (n = 30). The irradiation will be made using a diode laser emitting at 808 nm with 100 mW and 40 seconds of exposure per site at the salivary glands. Twenty sites will be irradiated weekly for 4 weeks. Non-stimulated and stimulated salivary flow will be analyzed before and after the treatment. Results: This protocol will determine the effectiveness of photodynamic therapy regarding the reduction of xerostomia in older adults using antihypertensive drugs. Conclusion: This protocol will determine the effectiveness of photodynamic therapy regarding the reduction of xerostomia in older adults using antihypertensive drugs. Trial registration: Clinicaltrials.gov – NCT03632096

Referência(s)